Androgen-Driven Fusion Genes and Chimeric Transcripts in Prostate Cancer

Area of Science:

• Endocrinology
• Molecular Biology
• Oncology

Background:

• Androgens are critical steroid hormones for male development and function.
• The androgen receptor (AR) mediates androgen effects and plays a key role in diseases like prostate cancer.
• Cancer cells exploit novel mechanisms for AR-mediated gene regulation.

Purpose of the Study:

• To review the prevalence, molecular mechanisms, and functional evidence of androgen-regulated fusion genes and transcripts in prostate cancer.
• To discuss the clinical relevance of specific fusion genes, such as TMPRSS2-ERG.
• To highlight open questions regarding prostate cancer fusions.

Main Methods:

• Literature review focusing on genetic rearrangements and transcriptional read-through mechanisms.
• Analysis of androgen-regulated genes, including protein-coding genes, pseudogenes, and non-coding RNAs.
• Discussion of functional evidence and clinical relevance of identified fusion events.

Main Results:

• Genetic rearrangements creating fusion genes are frequent in prostate cancer, linking androgen-regulated promoters to new genes.
• Transcriptional read-through mechanisms also connect previously unaffected genes to androgen regulation.
• Androgen regulation extends to pseudogenes and non-coding RNAs, potentially creating novel functions.

Conclusions:

• Androgen-regulated fusion genes and transcripts are significant in prostate cancer pathogenesis.
• The TMPRSS2-ERG fusion is a clinically relevant example of AR-driven oncogenesis.
• Further research is needed to fully understand the implications of these fusion events in prostate cancer.